NBT
AZN icon

Northwest Bank & Trust’s AstraZeneca AZN Stock Holding History

Northwest Bank & Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$3.72K Hold
28
– – ﹤0.01% 185
2024
Q3 		$4.28K Hold
28
– – ﹤0.01% 187
2024
Q2 		$4.29K Hold
28
– – ﹤0.01% 185
2024
Q1 		$4.17K Hold
28
– – ﹤0.01% 177
2023
Q4 		$3.7K Buy
+28
New +$3.64K ﹤0.01% 181
2023
Q2 		$3.94K Buy
+28
New +$4.12K ﹤0.01% 182

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Northwest Bank & Trust's AZN Position: Q4 2024 in Review

Northwest Bank & Trust held its AstraZeneca (AZN) position steady in Q4 2024 at 28 shares worth $3.72K. The position accounts for ﹤0.01% of the portfolio, ranked #185.

Northwest Bank & Trust first reported a position in AZN in Q2 2023 and has held it in 6 quarters since. The position peaked at $4.29K in Q2 2024. 1,219 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

  • Northwest Bank & Trust held 28 shares of AstraZeneca worth $3.72K as of Q4 2024.
  • Northwest Bank & Trust left its AstraZeneca share count unchanged in Q4 2024.
  • AstraZeneca made up ﹤0.01% of Northwest Bank & Trust's portfolio in Q4 2024, its #185 holding.
  • Northwest Bank & Trust first reported a position in AstraZeneca in Q2 2023 and has held it in 6 quarters since.
  • Northwest Bank & Trust's AstraZeneca position peaked at $4.29K in Q2 2024.
  • 1,219 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on Northwest Bank & Trust's 13F filing for Q4 2024, filed 18 Feb 2025.